• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

市售用于测量人类胰高血糖素和胰泌素的检测方法的特异性和敏感性。

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans.

机构信息

NNF Center for Basic Metabolic Research, Department of Biomedical Sciences, Faculty of Health Sciences.

出版信息

Eur J Endocrinol. 2014 Mar 8;170(4):529-38. doi: 10.1530/EJE-13-0941. Print 2014 Apr.

DOI:10.1530/EJE-13-0941
PMID:24412928
Abstract

AIM

To determine the specificity and sensitivity of assays carried out using commercially available kits for glucagon and/or oxyntomodulin measurements.

METHODS

Ten different assay kits used for the measurement of either glucagon or oxyntomodulin concentrations were obtained. Solutions of synthetic glucagon (proglucagon (PG) residues 3361), oxyntomodulin (PG residues 3369) and glicentin (PG residues 169) were prepared and peptide concentrations were verified by quantitative amino acid analysis and a processing-independent in-house RIA. Peptides were added to the matrix (assay buffer) supplied with the kits (concentration range: 1.25-300 pmol/l) and to human plasma and recoveries were determined. Assays yielding meaningful results were analysed for precision and sensitivity by repeated analysis and ability to discriminate low concentrations.

RESULTS AND CONCLUSION

Three assays were specific for glucagon (carried out using the Millipore (Billerica, MA, USA), Bio-Rad (Sundbyberg, Sweden), and ALPCO (Salem, NH, USA) and Yanaihara Institute (Shizuoka, Japan) kits), but none was specific for oxyntomodulin. The assay carried out using the Phoenix (Burlingame, CA, USA) glucagon kit measured the concentrations of all three peptides (total glucagon) equally. Sensitivity and precision were generally poor; the assay carried out using the Millipore RIA kit performed best with a sensitivity around 10 pmol/l. Assays carried out using the BlueGene (Shanghai, China), USCN LIFE (Wuhan, China) (oxyntomodulin and glucagon), MyBioSource (San Diego, CA, USA) and Phoenix oxyntomodulin kits yielded inconsistent results.

摘要

目的

确定使用市售试剂盒进行胰高血糖素和/或胰高血糖素样肽-1 测量的特异性和灵敏度。

方法

获得了用于测量胰高血糖素或胰高血糖素样肽-1 浓度的 10 种不同的测定试剂盒。制备了合成胰高血糖素(前胰高血糖素(PG)残基 3361)、胰高血糖素样肽-1(PG 残基 3369)和糖依赖性胰岛素释放肽(PG 残基 169)的溶液,并通过定量氨基酸分析和独立于加工的内部 RIA 验证了肽浓度。将肽添加到试剂盒提供的基质(测定缓冲液)中(浓度范围:1.25-300pmol/l)并添加到人血浆中,然后确定回收率。通过重复分析和区分低浓度的能力,对产生有意义结果的测定进行精密度和灵敏度分析。

结果和结论

有 3 种测定方法对胰高血糖素具有特异性(使用 Millipore(比勒陀利亚,MA,美国)、Bio-Rad(桑德比贝里,瑞典)和 ALPCO(塞勒姆,NH,美国)和矢野研究所(静冈,日本)试剂盒进行),但没有一种方法对胰高血糖素样肽-1 具有特异性。使用 Phoenix(伯林盖姆,CA,美国)胰高血糖素试剂盒进行的测定同样测量了所有三种肽(总胰高血糖素)的浓度。灵敏度和精密度通常较差;使用 Millipore RIA 试剂盒进行的测定具有约 10pmol/l 的灵敏度,效果最好。使用 BlueGene(上海,中国)、USCN LIFE(武汉,中国)(胰高血糖素和胰高血糖素样肽-1)、MyBioSource(圣地亚哥,CA,美国)和 Phoenix 胰高血糖素样肽-1 试剂盒进行的测定得出的结果不一致。

相似文献

1
Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans.市售用于测量人类胰高血糖素和胰泌素的检测方法的特异性和敏感性。
Eur J Endocrinol. 2014 Mar 8;170(4):529-38. doi: 10.1530/EJE-13-0941. Print 2014 Apr.
2
Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies.胰高血糖素样肽-1(GLP-1)商业检测方法的特异性和敏感性:对临床研究中GLP-1测量的影响。
Diabetes Obes Metab. 2014 Nov;16(11):1155-64. doi: 10.1111/dom.12352. Epub 2014 Jul 22.
3
Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial.方法论文:新型循环胰高血糖素原衍生肽检测方法的性能特征及其在安慰剂对照交叉随机临床试验中的验证。
Metabolism. 2022 Apr;129:155157. doi: 10.1016/j.metabol.2022.155157. Epub 2022 Feb 1.
4
Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.胃泌酸调节素和胰高血糖素在大鼠胃肠道及血浆中的分布
Endocrinology. 1987 Aug;121(2):704-13. doi: 10.1210/endo-121-2-704.
5
Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme-linked immunosorbent assay.采用新型酶联免疫吸附试验分析 2 型糖尿病患者的餐后高胰高血糖素血症。
J Diabetes Investig. 2016 May;7(3):324-31. doi: 10.1111/jdi.12400. Epub 2015 Aug 24.
6
Oxyntomodulin and glicentin: brain-gut peptides in the rat.胃泌酸调节素与胰高血糖素:大鼠体内的脑肠肽
Endocrinology. 1988 Dec;123(6):2782-7. doi: 10.1210/endo-123-6-2782.
7
Enteroglucagon.肠高血糖素
Annu Rev Physiol. 1997;59:257-71. doi: 10.1146/annurev.physiol.59.1.257.
8
Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test.餐后耐量试验后通过免疫亲和富集和串联质谱法对胰高血糖素原衍生肽进行多重定量分析
Clin Chem. 2016 Jan;62(1):227-35. doi: 10.1373/clinchem.2015.244251. Epub 2015 Oct 1.
9
A novel high-sensitivity electrochemiluminescence (ECL) sandwich immunoassay for the specific quantitative measurement of plasma glucagon.一种新型高灵敏度电化学发光(ECL)夹心免疫分析法,用于特异性定量测量血浆胰高血糖素。
Clin Biochem. 2012 Dec;45(18):1640-4. doi: 10.1016/j.clinbiochem.2012.07.111. Epub 2012 Aug 4.
10
Response to lowering plasma glucose is characterised by decreased oxyntomodulin: Results from a randomised controlled trial.降低血浆葡萄糖反应的特征是肠抑胃肽减少:一项随机对照试验的结果。
Diabetes Metab Syndr. 2024 Jun;18(6):103052. doi: 10.1016/j.dsx.2024.103052. Epub 2024 Jun 10.

引用本文的文献

1
Effect of SGLT2 Inhibition on Glucosuria During a Hyperglycemic Clamp in HNF1A-MODY (MODY3) and Type 2 Diabetes.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂对肝细胞核因子1α(HNF1A)-成年发病型糖尿病(MODY)(MODY3)及2型糖尿病患者高血糖钳夹期间糖尿的影响。
Diabetes Care. 2025 Sep 1;48(9):1536-1544. doi: 10.2337/dc25-0737.
2
Quantification of glucagon and oxyntomodulin by protein precipitation-immunoaffinity enrichment-LC-MS/MS.通过蛋白质沉淀-免疫亲和富集-LC-MS/MS对胰高血糖素和胃泌酸调节素进行定量分析。
J Mass Spectrom Adv Clin Lab. 2025 Apr 11;36:37-45. doi: 10.1016/j.jmsacl.2025.04.002. eCollection 2025 Apr.
3
Role of serum fasting glucagon in hypothyroidism-related nonalcoholic fatty liver disease.
血清空腹胰高血糖素在甲状腺功能减退症相关非酒精性脂肪性肝病中的作用。
Nutr Metab (Lond). 2025 Mar 11;22(1):19. doi: 10.1186/s12986-025-00899-z.
4
Enhanced quantification of α-cell suppression by hyperglycemia using a high-sensitivity glucagon assay.使用高灵敏度胰高血糖素测定法增强高血糖对α细胞抑制作用的量化。
Am J Physiol Endocrinol Metab. 2025 Jan 1;328(1):E62-E68. doi: 10.1152/ajpendo.00301.2024. Epub 2024 Dec 9.
5
Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption.胆汁酸吸收不良个体的肠肝循环、糖代谢及肠道微生物特征
Gastro Hep Adv. 2022 Mar 30;1(3):299-312. doi: 10.1016/j.gastha.2021.12.007. eCollection 2022.
6
Advances in the clinical measurement of glucagon: from diagnosis to therapy.胰高血糖素临床测量的进展:从诊断到治疗。
Diabetol Int. 2024 Mar 27;15(3):362-369. doi: 10.1007/s13340-024-00704-x. eCollection 2024 Jul.
7
Diabetes-associated Genetic Variation in and Its Effect on Islet Function.糖尿病相关基因变异及其对胰岛功能的影响。
J Endocr Soc. 2024 Jul 9;8(8):bvae130. doi: 10.1210/jendso/bvae130. eCollection 2024 Jul 1.
8
Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice.依格列净通过间接机制增强胰高血糖素分泌,并改善高脂肪、高蔗糖饮食喂养的小鼠的脂肪肝。
J Diabetes Investig. 2024 Sep;15(9):1177-1190. doi: 10.1111/jdi.14249. Epub 2024 Jun 14.
9
Fasting and post prandial pancreatic and enteroendocrine hormone levels in obese and non-obese participants.肥胖与非肥胖参与者的空腹及餐后胰腺和肠内分泌激素水平。
Peptides. 2024 Jun;176:171186. doi: 10.1016/j.peptides.2024.171186. Epub 2024 Mar 13.
10
Comparison of an oral mixed meal plus arginine and intravenous glucose, GLP-1 plus arginine to unmask residual islet function in longstanding type 1 diabetes.口服混合餐加精氨酸与静脉葡萄糖、GLP-1 加精氨酸对比在长期 1 型糖尿病患者中检测残余胰岛功能。
Am J Physiol Endocrinol Metab. 2024 May 1;326(5):E673-E680. doi: 10.1152/ajpendo.00030.2024. Epub 2024 Mar 6.